Viewing Study NCT00685061


Ignite Creation Date: 2025-12-24 @ 12:12 PM
Ignite Modification Date: 2026-01-23 @ 12:01 AM
Study NCT ID: NCT00685061
Status: COMPLETED
Last Update Posted: 2023-10-18
First Post: 2008-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation
Sponsor: University of Miami
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adult, primary deceased donor kidney transplant recipients View